111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.98%
Revenue decline while CX shows 13.18% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-70.36%
Gross profit decline while CX shows 16.20% growth. Joel Greenblatt would examine competitive position.
-70.06%
Margin decline while CX shows 2.66% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-92.61%
EBITDA decline while CX shows 38.30% growth. Joel Greenblatt would examine position.
-93.10%
EBITDA margin decline while CX shows 28.72% growth. Joel Greenblatt would examine position.
-93.49%
Operating income decline while CX shows 26.08% growth. Joel Greenblatt would examine position.
-93.42%
Operating margin decline while CX shows 11.39% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.96%
Tax expense growth above 1.5x CX's 17.94%. Michael Burry would check for concerning trends.
-0.98%
Net income decline while CX shows 16.04% growth. Joel Greenblatt would examine position.
0.00%
Net margin growth below 50% of CX's 2.53%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.04%
Share count increase while CX reduces shares. John Neff would investigate differences.
-0.02%
Both companies reducing diluted shares. Martin Whitman would check patterns.